Best Antidepressant for IBS with Constipation

Rationale for SSRIs in IBS-C

• The American Gastroenterological Association suggests against using SSRIs in general IBS populations due to inconsistent evidence (conditional recommendation, low certainty), with studies showing possible but not definitive improvement (RR 0.74; 95% CI 0.52-1.06) 4, 2, 3
• The British Society of Gastroenterology gives SSRIs a weak recommendation with low-quality evidence for global IBS symptoms 1, 5, 6

Why Not TCAs in IBS-C

• The guidelines explicitly state that secondary amine TCAs (desipramine and nortriptyline) may be better tolerated in IBS-C patients due to their lower anticholinergic effects compared to tertiary amines like amitriptyline 2, 3
• If a TCA must be used in IBS-C, choose desipramine or nortriptyline over amitriptyline 2, 3

Practical Prescribing Approach

• When prescribing an SSRI for IBS-C, start with citalopram 20 mg daily, which can be increased to 40 mg after 2-4 weeks if needed 4, 2, 3
• Alternative SSRIs include paroxetine 10 mg daily (can be increased) or fluoxetine 20 mg daily 4, 2, 3
• Explain that these medications are being used as "gut-brain neuromodulators" rather than for depression, which improves patient acceptance 1, 5, 6, 9

Important Caveats

• If the patient has concurrent moderate-to-severe depression or anxiety, an SSRI at standard antidepressant doses is clearly preferred because low-dose TCAs used for IBS are unlikely to address psychological symptoms adequately 9
• The evidence for SSRIs in IBS remains weak overall - they did not significantly improve global symptoms or abdominal pain in pooled analyses, though individual patients may benefit 4, 2, 3

Alternative Consideration

• For IBS-C specifically, secretagogues like linaclotide are more effective than antidepressants for constipation and pain (strong recommendation, high-quality evidence), and should be considered as second-line pharmacotherapy before or alongside antidepressants 1, 5, 6